196
Participants
Start Date
September 11, 2019
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2027
Vitamin C
Oral vitamin C (ascorbic acid) 1000 mg daily will be administered from day 1 in the 1st AZA cycle (D1/C1) and continued until discontinuation of AZA or EOS as combination treatment.
Placebo
Placebo capsules (two capsules once daily) will be administered from day 1 in the 1st AZA cycle (D1/C1) and continued until discontinuation of AZA or EOS.
RECRUITING
Rigshospitalet, Copenhagen
RECRUITING
Herlev University Hospital, Copenhagen
ACTIVE_NOT_RECRUITING
Odense University Hospital, Odense
RECRUITING
Aalborg University Hospital, Aalborg
RECRUITING
Aarhus University Hospital, Aarhus
TERMINATED
Zealand University Hospital, Roskilde
RECRUITING
Sahlgrenska University Hospital, Gothenburg
RECRUITING
Skåne University Hospital, Lund
RECRUITING
Karolinska University Hospital, Stockholm
RECRUITING
Uppsala University Hospital, Uppsala
Van Andel Institute - Stand Up To Cancer Epigenetics Dream Team
UNKNOWN
Karolinska University Hospital
OTHER
Skane University Hospital
OTHER
Sahlgrenska University Hospital
OTHER
University of Southern California
OTHER
Imperial College London
OTHER
University of Copenhagen
OTHER
Zealand University Hospital
OTHER
Aalborg University Hospital
OTHER
Odense University Hospital
OTHER
Technical University of Denmark
OTHER
Aarhus University Hospital
OTHER
Uppsala University Hospital
OTHER
Kirsten Grønbæk
OTHER